James T Lenehan
CIK 1189009 · last filed 2021-05-04
James T Lenehan is a corporate insider who has filed 31 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for MDT, was dated May 4, 2021. Across all open-market trades the lifetime net is +$146.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $5.8M across reported positions. 20 SEC filings were submitted jointly with Medtronic plc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MDT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS, MN 55432
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDT | Director | 57,849 | $100.28 | $5.80M | $146.2K | 29 | 2021-05-04 |
| Talecris Biotherapeutics Holdings Corp. (TLCR) Delisted | Director | 139,891 | — | — | $0 | 1 | 2010-04-05 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-04 | MDT | Grant (A) | +1,334 | $0 | EDGAR |
| 2021-04-28 | MDT | Tax (F) | −426 | -$55.4K | EDGAR |
| 2020-04-30 | MDT | Tax (F) | −393 | -$39.0K | EDGAR |
| 2020-04-29 | MDT | Grant (A) | +1,737 | $0 | EDGAR |
| 2019-09-26 | MDT | Mixed | +1,069 | -$62 | EDGAR |
| 2019-06-12 | MDT | Mixed | +1,573 | -$38.1K | EDGAR |
| 2019-05-01 | MDT | Mixed | +1,573 | -$38.1K | EDGAR |
| 2019-03-05 | MDT | Exer (M) | +2,671 | $80.0K | EDGAR |
| 2018-05-02 | MDT | Mixed | +1,568 | -$49.9K | EDGAR |
| 2018-03-14 | MDT | Mixed | +284 | -$29.1K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).